Chondrosarcoma

• CLINICAL_TRIALS trial_result · 2014-01-30
  Clinical Trial Update: Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery [Phase 2]

  Phase 2 trial results for Therapeutic Angiotensin-(1-7) in patients with unresectable metastatic sarcoma have results posted.

• CLINICAL_TRIALS trial_result · 2013-12-05
  Clinical Trial Update: A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma [Phase 2]

  Phase 2 safety and efficacy study of saridegib (IPI-926) in patients with metastatic or locally advanced chondrosarcoma completed.

• CLINICAL_TRIALS trial_result · 2013-11-08
  Clinical Trial Update: S9624 Ifosfamide in Treating Patients With Meningeal Tumors [Phase 2]

  Phase 2 SWOG trial of ifosfamide for meningeal tumors and related sarcomas was terminated.

• CLINICAL_TRIALS trial_result · 2013-02-07
  Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma [Phase 1]

  This Phase 1 trial evaluated the Hsp90 inhibitor tanespimycin (17-AAG) in patients with advanced epithelial cancers, malignant lymphomas, or…

• CLINICAL_TRIALS trial_result · 2012-11-14
  Clinical Trial Update: IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 [NA]

  Clinical trial update for the extension protocol of IPI-926 (saridegib) for continuation of treatment; the study involving basal cell carcin…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2012-03-12
  Clinical Trial Update: Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma [Phase 2]

  Phase 2 trial evaluating gemcitabine and docetaxel in patients with recurrent osteosarcoma, Ewing's sarcoma, or unresectable/locally recurre…

• CLINICAL_TRIALS trial_result · 2012-01-18
  Clinical Trial Update: S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma [Phase 2]

  Phase 2 trial evaluating pemetrexed disodium for recurrent and unresectable or metastatic chondrosarcoma has been completed.